Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Disease Flare in Patients With Rheumatoid Arthritis-Reply

JAMA. 2021 Sep 7;326(9):873. doi: 10.1001/jama.2021.10651.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Arthritis, Rheumatoid* / drug therapy
  • Humans
  • Methotrexate / therapeutic use
  • Symptom Flare Up

Substances

  • Antirheumatic Agents
  • Methotrexate